Contact
      Please use this form to send email to PR contact of this press release:
      
      Diverse Biotech Inc. Receives Landmark USPTO Patent Allowance for Disruptive Dual-Action Therapeutic Class
    
      TO:
      
      William Fisher
      
      Diverse Biotech, Inc.
      
      +1 352-552-8985